KENILWORTH, N.J.–(BUSINESS WIRE) October 16, 2020 — Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced positive results from two
Read more
Home »
Oncternal Therapeutics Receives Rare Pediatric Disease Designation from U.S. Food and Drug Administration for TK216 for Treatment of Ewing Sarcoma
SAN DIEGO–(BUSINESS WIRE)–Oct. 6, 2020– Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced that the U.S. Food
Read more
COVID-19 Vaccine AZD1222 Clinical Trial Resumed in Japan, Follows Restart of Trials in the UK, Brazil, South Africa and India
2 October 2020 — The Phase I/II clinical trial for the COVID-19 vaccine AZD1222 has resumed in Japan after discussion with the Japanese Pharmaceuticals and
Read more
Study shows gaps in healthcare workers’ knowledge and attitudes about antibiotics
Knowledge and awareness of antibiotic resistance and related issues is generally high among European healthcare workers, according to the first European survey to examine attitudes
Read more
CDC: Drugs involved in overdose deaths varied regionally in 2017
(HealthDay)—The drugs most frequently involved in drug overdose deaths in 2017 varied regionally in the United States, according to a study published online Oct. 25
Read more
Breathalyzer for weed could be a ‘game changer’ for legalization efforts
When New Jersey lawmakers debated earlier this year whether to legalize recreational use of marijuana, the Garden State’s police organizations were adamantly against it. The
Read more
Introduce standard units for cannabis to improve mental health
New findings suggest that introducing ‘standard units’ for cannabis could improve people’s mental health. Despite widespread use of the drug around the world and increasing
Read more
How microbes hack into cells and why cancer drugs might block them
No matter the pathogen—virus, bacterium or fungus—many “pick a specific type of lock” on the surface of cells, which allows the microbe to break and
Read more
First targeted therapy for cholangiocarcinoma shows clinical benefit in phase III trial
New data have shown for the first time that targeted therapy can improve the outcome of patients diagnosed with advanced cholangiocarcinoma. Cholangiocarcinoma is a subtype
Read more
Mylan in $30 mn US settlement over EpiPen probe disclosures
Mylan will pay $30 million to settle US charges it misled investors about probes of EpiPen payments under a federal health program, a US securities
Read more